Yunnan Baiyao GroupLtd Future Growth
Future criteria checks 1/6
Yunnan Baiyao GroupLtd is forecast to grow earnings and revenue by 9.4% and 7% per annum respectively. EPS is expected to grow by 9.4% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
9.4%
Earnings growth rate
9.4%
EPS growth rate
| Pharmaceuticals earnings growth | 17.8% |
| Revenue growth rate | 7.0% |
| Future return on equity | 13.3% |
| Analyst coverage | Good |
| Last updated | 08 Aug 2024 |
Recent future growth updates
Recent updates
Yunnan Baiyao GroupLtd (SZSE:000538) Could Easily Take On More Debt
Aug 06
A Look At The Intrinsic Value Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538)
Jun 30Earnings Working Against Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Share Price
Apr 21Yunnan Baiyao Group Co.,Ltd Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Apr 02Yunnan Baiyao Group Co.,Ltd (SZSE:000538) Shares Could Be 34% Above Their Intrinsic Value Estimate
Feb 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 48,371 | 5,601 | 5,420 | 4,328 | 12 |
| 12/31/2025 | 45,429 | 5,061 | 4,758 | 4,051 | 14 |
| 12/31/2024 | 42,285 | 4,591 | 4,121 | 3,572 | 14 |
| 3/31/2024 | 39,373 | 4,278 | 2,760 | 3,296 | N/A |
| 12/31/2023 | 39,111 | 4,094 | 2,927 | 3,503 | N/A |
| 9/30/2023 | 39,261 | 4,820 | 3,325 | 3,857 | N/A |
| 6/30/2023 | 38,781 | 4,329 | 3,766 | 4,283 | N/A |
| 3/31/2023 | 37,572 | 3,605 | 3,658 | 4,113 | N/A |
| 1/1/2023 | 36,488 | 3,001 | 2,763 | 3,209 | N/A |
| 9/30/2022 | 34,927 | 2,659 | 367 | 632 | N/A |
| 6/30/2022 | 35,308 | 2,504 | 2,787 | 3,186 | N/A |
| 3/31/2022 | 35,476 | 2,956 | 4,656 | 5,181 | N/A |
| 1/1/2022 | 36,374 | 2,805 | 4,689 | 5,223 | N/A |
| 9/30/2021 | 37,174 | 3,714 | 6,152 | 6,870 | N/A |
| 6/30/2021 | 36,332 | 4,864 | 4,192 | 4,755 | N/A |
| 3/31/2021 | 35,327 | 4,997 | 2,784 | 3,208 | N/A |
| 12/31/2020 | 32,743 | 5,516 | 3,342 | 3,829 | N/A |
| 9/30/2020 | 31,950 | 4,895 | 4,925 | 5,444 | N/A |
| 6/30/2020 | 31,261 | 4,390 | 4,182 | 4,845 | N/A |
| 3/31/2020 | 30,402 | 3,509 | 2,116 | 2,947 | N/A |
| 12/31/2019 | 29,665 | 4,184 | 1,321 | 2,105 | N/A |
| 9/30/2019 | 28,686 | 3,740 | -395 | 414 | N/A |
| 6/30/2019 | 27,769 | 3,671 | -3,441 | -2,707 | N/A |
| 3/31/2019 | 27,685 | 4,644 | 195 | 874 | N/A |
| 1/1/2019 | 27,017 | 3,494 | 993 | 1,549 | N/A |
| 9/30/2018 | 26,284 | 3,836 | 768 | 1,219 | N/A |
| 6/30/2018 | 25,499 | 3,649 | 3,728 | 4,047 | N/A |
| 3/31/2018 | 24,743 | 3,226 | 2,164 | 2,343 | N/A |
| 12/31/2017 | 24,315 | 3,145 | N/A | 1,156 | N/A |
| 9/30/2017 | 24,131 | 3,165 | N/A | 1,418 | N/A |
| 6/30/2017 | 23,919 | 3,097 | N/A | 1,807 | N/A |
| 3/31/2017 | 23,149 | 3,023 | N/A | 1,199 | N/A |
| 12/31/2016 | 22,411 | 2,920 | N/A | 2,985 | N/A |
| 9/30/2016 | 22,338 | 2,989 | N/A | 3,056 | N/A |
| 6/30/2016 | 21,648 | 2,904 | N/A | 2,329 | N/A |
| 3/31/2016 | 21,200 | 2,831 | N/A | 2,272 | N/A |
| 12/31/2015 | 20,738 | 2,771 | N/A | 2,180 | N/A |
| 9/30/2015 | 20,185 | 2,704 | N/A | 2,125 | N/A |
| 6/30/2015 | 19,730 | 2,631 | N/A | 2,371 | N/A |
| 3/31/2015 | 19,364 | 2,564 | N/A | 1,752 | N/A |
| 12/31/2014 | 18,814 | 2,506 | N/A | 1,587 | N/A |
| 9/30/2014 | 17,904 | 2,507 | N/A | 1,238 | N/A |
| 6/30/2014 | 17,131 | 2,515 | N/A | 1,121 | N/A |
| 3/31/2014 | 16,625 | 2,450 | N/A | 1,031 | N/A |
| 12/31/2013 | 15,815 | 2,321 | N/A | 342 | N/A |
| 9/30/2013 | 15,384 | 2,220 | N/A | 820 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 000538's forecast earnings growth (9.4% per year) is above the savings rate (2.9%).
Earnings vs Market: 000538's earnings (9.4% per year) are forecast to grow slower than the CN market (21.8% per year).
High Growth Earnings: 000538's earnings are forecast to grow, but not significantly.
Revenue vs Market: 000538's revenue (7% per year) is forecast to grow slower than the CN market (13.4% per year).
High Growth Revenue: 000538's revenue (7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 000538's Return on Equity is forecast to be low in 3 years time (13.3%).